Evidence map›Paper›PMID 34930023›Full record

ArticleAntimicrobial agents and chemotherapy2022

Staphylococcus aureus Efflux Pumps and Tolerance to Ciprofloxacin and Chlorhexidine following Induction by Mupirocin.

Q C Truong-Bolduc, Y Wang, J L Reedy, J M Vyas, D C Hooper

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Mechanisms ofInternational journal of molecular sciences · 2025
    Article
  5. Phenazine-1 carboxylic acid ofAntimicrobial agents and chemotherapy · 2024
    Article
  6. Antimicrobial agents and chemotherapy · 2024
    Article
  7. NorA efflux pump mediatesAntimicrobial agents and chemotherapy · 2024
    Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Q C Truong-BolducInfectious Diseases Division and Medical Services, Massachusetts General Hospitalgrid.32224.35, Harvard Medical School, Boston, Massachusetts, USA.
Y WangInfectious Diseases Division and Medical Services, Massachusetts General Hospitalgrid.32224.35, Harvard Medical School, Boston, Massachusetts, USA.
J L ReedyInfectious Diseases Division and Medical Services, Massachusetts General Hospitalgrid.32224.35, Harvard Medical School, Boston, Massachusetts, USA.
J M VyasInfectious Diseases Division and Medical Services, Massachusetts General Hospitalgrid.32224.35, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9985-9565
D C HooperInfectious Diseases Division and Medical Services, Massachusetts General Hospitalgrid.32224.35, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-1444-9939
Harvard University · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI Johan Paulsson · 2009 to 2026
$39.4M
Control of Type I Interferon Production in Response to Candida albicansR01AI150181 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Jatin M Vyas · 2020 to 2026
$5.4M
The Functional Role of the Tetraspanin CD82/Kai1 in Fungal Innate ImmunityR01AI136529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2018 to 2022
$2.7M
Innate Immune Response to Aspergillus fumigatus Cell Wall CarbohydratesK08AI141755 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REEDY, JENNIFER LYNNE · 2019 to 2022
$799k
NIAID NIH HHS K08 AI141755NIAID NIH HHS P01 AI083214
6 · The paper itself

Abstract

Mupirocin induced expression of genes encoding efflux pumps NorA and MepA as well as a yellow fluorescent protein (YFP) fluorescence reporter of NorA. Mupirocin exposure also produced reduced susceptibility to pump substrates ciprofloxacin and chlorhexidine, a change that was dependent on intact

Indexed as

CiprofloxacinStaphylococcus aureusAnti-Bacterial AgentsATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsChlorhexidineMicrobial Sensitivity TestsMupirocinAnti-Bacterial AgentsATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsChlorhexidineCiprofloxacinMupirocinchlorhexidineciprofloxacinMepAmupirocinNorAStaphylococcus aureus

Identifiers

PMID34930023
PMCPMC8846467
OpenAlexW4200182944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.